Skip to main navigation Skip to search Skip to main content

Pilot Study of Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin Shows Reduced Intrarenal Complement Activation in Patients With Diabetes and CKD

  • Gødstrup Hospital
  • Aarhus University

Research output: Contribution to journalJournal articleResearchpeer-review

31 Downloads (Pure)
Original languageEnglish
JournalKidney International Reports
Volume10
Issue number2
Pages (from-to)591-595
ISSN2468-0249
DOIs
Publication statusPublished - Feb 2025

Keywords

  • kidney injury
  • lectin cascade
  • type 2 diabetes mellitus

Cite this